Results for "consumer data right"
221-230 of 560 results for 'consumer data right'
The Mark of Milk and Money: a2 vs Lion
The widely reported dispute between The a2 Milk Company and Lion about their milk advertising is proving to be a frothy fight, providing food manufacturers with valuable lessons, even before a judgment has been handed down. ...
Using tech and data in a crisis – contact tracing
Data analysis, and the technology that facilitates it, is currently playing a critical role in the global and national efforts to combat the COVID-19 pandemic. Alongside the front-line health response, it has become a core part of the daily calculations made by governments and health organisations. ...
TGA guidance on the promotion of stem cells and HCT products
The Therapeutic Goods Administration has issued advertising guidance for businesses involved with stems cells and other human cell or tissue products. ...
Making the quantum computing leap
The Federal Government's recent National Quantum Strategy and FY2023–24 Budget signal a strong commitment to growing Australia's quantum computing sector. To assist organisations aiming to capitalise on that renewed focus, this Insight gives an overview of the technology and the legal issues. ...
Booking.com not so generic.com in the US?
The US Supreme Court held that Booking.com is not a generic term and can be registered as a trade mark, presenting an opportunity for online businesses trading in the US under 'generic.com' domain names to seek trade mark registration. ...
Peer-to-peer lending - a disruptive threat to banks?
The expansion of peer to peer lending in Australia will likely be a disruptive force for both banks and broader commercial stakeholders ...
Class action risk: interim update
Filings are down, but impact too early to call. 2022 is shaping up as the year that bucks a number of long-running class action trends. Filings are materially down on prior years, and the claims that have been filed are somewhat at odds with recent trends. ...
PBS process proving a headache for migraine medications
Challenging a PBAC decision is not straightforward. We take a look at the available options and examine the alleged delays in listing migraine treatments Emgality and Ajovy on the PBS. ...
Gaming: it's no game, in fact, it's big business
From Nintendo to esports, gaming has put on a masterclass, demonstrating how leveraging and protecting IP is a key companion to reaching audiences beyond the controller. ...
No longer 'once in a blue moon': bluewashing risks and challenges can't be ignored
In this Insight, we explain why companies should carefully consider their representations about human rights and other social issues, and how to manage associated bluewashing risk. ...